Core Insights - Cambridge Technology (603083.SH) clarifies that it currently does not produce chips containing CPO (Co-Packaged Optics) technology, and that the core components related to CPO are still in the collaborative research and design phase, with no business revenue generated yet [1] - The LPO (Linear Drive Optical) business has sent samples for testing to several major North American clients, but the cumulative order and shipment amount for the first half of 2025 accounts for only about 0.03% of the company's revenue during the same period, indicating minimal contribution to current performance [1] - The company advises investors to rationally assess the progress in emerging technology fields and not to overinterpret the impact of these related businesses on short-term performance, highlighting the uncertainty risks associated with business implementation [1]

Group 1 - The CPO concept stocks in the A-share market continue to perform strongly, with notable increases in share prices for companies such as Shijia Photon (up 13.34%), Xinyi Sheng (up 11.60%), and Cambridge Technology (up 10.00%) [1][2] - The total market capitalization of these companies varies significantly, with Xinyi Sheng having a market cap of 312.8 billion and Shijia Photon at 36.6 billion [2] - Year-to-date performance shows substantial growth, with Shijia Photon up 388.17% and Xinyi Sheng up 282.81% [2] Group 2 - Zhongji Xuchuang reported a revenue of 14.789 billion for the first half of 2025, representing a year-on-year growth of 36.95%, and a net profit of 3.995 billion, up 69.40% [2] - The company plans to distribute a cash dividend of 4 yuan per 10 shares based on 1.111 billion shares [2] Group 3 - Cambridge Technology clarified that it does not currently produce chips containing CPO technology, and its related core components are still in the research and design phase, with no business revenue generated yet [3] - The LPO business has sent samples to several North American clients, but the cumulative orders and shipment amounts for the first half of 2025 account for only about 0.03% of the company's revenue during the same period [3] - Investors are advised to rationally assess the company's progress in emerging technologies and not to overinterpret the short-term impact on performance [3]